世界の消費者直接提供用病気リスク&健康検査市場規模・現状・予測2021-2027

【英語タイトル】Global Direct-to-consumer Disease Risk and Health Test Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21JNE3710)・商品コード:QY21JNE3710
・発行会社(調査会社):QYResearch
・発行日:2021年6月
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、消費者直接提供用病気リスク&健康検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(セリアック病、パーキンソン病、アルツハイマー病、その他)、用途別市場規模(オンライン、オフライン)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・消費者直接提供用病気リスク&健康検査の市場動向
・企業の競争状況、市場シェア
・消費者直接提供用病気リスク&健康検査の種類別市場規模(セリアック病、パーキンソン病、アルツハイマー病、その他)
・消費者直接提供用病気リスク&健康検査の用途別市場規模(オンライン、オフライン)
・消費者直接提供用病気リスク&健康検査の北米市場規模2016-2027(アメリカ、カナダ)
・消費者直接提供用病気リスク&健康検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・消費者直接提供用病気リスク&健康検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・消費者直接提供用病気リスク&健康検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・消費者直接提供用病気リスク&健康検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(23andMe、MyHeritage、LabCorp、Myriad Genetics、Ancestry.com、Quest Diagnostics、Gene By Gene、DNA Diagnostics Center、Invitae、IntelliGenetics、Ambry Genetics、Living DNA、EasyDNA、Pathway Genomics、Centrillion Technology、Xcode、Color Genomics、Anglia DNA Services、African Ancestry、Canadian DNA Services、DNA Family Check、Alpha Biolaboratories、Test Me DNA、23 Mofang、Genetic Health、DNA Services of America、Shuwen Health Sciences、Mapmygenome、Full Genomes)
・結論
【レポートの概要】

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

Market Analysis and Insights: Global Direct-to-consumer Disease Risk and Health Test Market
The global Direct-to-consumer Disease Risk and Health Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Direct-to-consumer Disease Risk and Health Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Direct-to-consumer Disease Risk and Health Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Direct-to-consumer Disease Risk and Health Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Direct-to-consumer Disease Risk and Health Test market.

Global Direct-to-consumer Disease Risk and Health Test Scope and Market Size
Direct-to-consumer Disease Risk and Health Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Direct-to-consumer Disease Risk and Health Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Segment by Application
Online
Offline

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Celiac Disease
1.2.3 Parkinson Disease
1.2.4 Alzheimer Disease
1.2.5 Other
1.3 Market by Application
1.3.1 Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Direct-to-consumer Disease Risk and Health Test Market Perspective (2016-2027)
2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Regions
2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Direct-to-consumer Disease Risk and Health Test Historic Market Share by Regions (2016-2021)
2.2.3 Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Regions (2022-2027)
2.3 Direct-to-consumer Disease Risk and Health Test Industry Dynamic
2.3.1 Direct-to-consumer Disease Risk and Health Test Market Trends
2.3.2 Direct-to-consumer Disease Risk and Health Test Market Drivers
2.3.3 Direct-to-consumer Disease Risk and Health Test Market Challenges
2.3.4 Direct-to-consumer Disease Risk and Health Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue
3.1.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue (2016-2021)
3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2016-2021)
3.2 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
3.4 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio
3.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Test Revenue in 2020
3.5 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
3.6 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
3.7 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Type
4.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2016-2021)
4.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2022-2027)

5 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Application
5.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Application (2016-2021)
5.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2016-2027)
6.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type
6.2.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021)
6.2.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027)
6.2.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2027)
6.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application
6.3.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021)
6.3.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027)
6.3.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2027)
6.4 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country
6.4.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021)
6.4.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2016-2027)
7.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type
7.2.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021)
7.2.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027)
7.2.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2027)
7.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application
7.3.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021)
7.3.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027)
7.3.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2027)
7.4 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country
7.4.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021)
7.4.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size (2016-2027)
8.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type
8.2.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application
8.3.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region
8.4.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size (2016-2027)
9.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type
9.2.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021)
9.2.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027)
9.2.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2027)
9.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application
9.3.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021)
9.3.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027)
9.3.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2027)
9.4 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country
9.4.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021)
9.4.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size (2016-2027)
10.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type
10.2.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application
10.3.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country
10.4.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Details
11.1.2 23andMe Business Overview
11.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction
11.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.1.5 23andMe Recent Development
11.2 MyHeritage
11.2.1 MyHeritage Company Details
11.2.2 MyHeritage Business Overview
11.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction
11.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.2.5 MyHeritage Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Details
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction
11.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.3.5 LabCorp Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction
11.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.4.5 Myriad Genetics Recent Development
11.5 Ancestry.com
11.5.1 Ancestry.com Company Details
11.5.2 Ancestry.com Business Overview
11.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction
11.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.5.5 Ancestry.com Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction
11.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.6.5 Quest Diagnostics Recent Development
11.7 Gene By Gene
11.7.1 Gene By Gene Company Details
11.7.2 Gene By Gene Business Overview
11.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction
11.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.7.5 Gene By Gene Recent Development
11.8 DNA Diagnostics Center
11.8.1 DNA Diagnostics Center Company Details
11.8.2 DNA Diagnostics Center Business Overview
11.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction
11.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.8.5 DNA Diagnostics Center Recent Development
11.9 Invitae
11.9.1 Invitae Company Details
11.9.2 Invitae Business Overview
11.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction
11.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.9.5 Invitae Recent Development
11.10 IntelliGenetics
11.10.1 IntelliGenetics Company Details
11.10.2 IntelliGenetics Business Overview
11.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction
11.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.10.5 IntelliGenetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Details
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction
11.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.11.5 Ambry Genetics Recent Development
11.12 Living DNA
11.12.1 Living DNA Company Details
11.12.2 Living DNA Business Overview
11.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction
11.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.12.5 Living DNA Recent Development
11.13 EasyDNA
11.13.1 EasyDNA Company Details
11.13.2 EasyDNA Business Overview
11.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction
11.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.13.5 EasyDNA Recent Development
11.14 Pathway Genomics
11.14.1 Pathway Genomics Company Details
11.14.2 Pathway Genomics Business Overview
11.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction
11.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.14.5 Pathway Genomics Recent Development
11.15 Centrillion Technology
11.15.1 Centrillion Technology Company Details
11.15.2 Centrillion Technology Business Overview
11.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction
11.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.15.5 Centrillion Technology Recent Development
11.16 Xcode
11.16.1 Xcode Company Details
11.16.2 Xcode Business Overview
11.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction
11.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.16.5 Xcode Recent Development
11.17 Color Genomics
11.17.1 Color Genomics Company Details
11.17.2 Color Genomics Business Overview
11.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction
11.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.17.5 Color Genomics Recent Development
11.18 Anglia DNA Services
11.18.1 Anglia DNA Services Company Details
11.18.2 Anglia DNA Services Business Overview
11.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
11.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.18.5 Anglia DNA Services Recent Development
11.18 African Ancestry
11.25.1 African Ancestry Company Details
11.25.2 African Ancestry Business Overview
11.25.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction
11.25.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.25.5 African Ancestry Recent Development
11.20 Canadian DNA Services
11.20.1 Canadian DNA Services Company Details
11.20.2 Canadian DNA Services Business Overview
11.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
11.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.20.5 Canadian DNA Services Recent Development
11.21 DNA Family Check
11.21.1 DNA Family Check Company Details
11.21.2 DNA Family Check Business Overview
11.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction
11.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.21.5 DNA Family Check Recent Development
11.22 Alpha Biolaboratories
11.22.1 Alpha Biolaboratories Company Details
11.22.2 Alpha Biolaboratories Business Overview
11.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction
11.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.22.5 Alpha Biolaboratories Recent Development
11.23 Test Me DNA
11.23.1 Test Me DNA Company Details
11.23.2 Test Me DNA Business Overview
11.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction
11.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.23.5 Test Me DNA Recent Development
11.24 23 Mofang
11.24.1 23 Mofang Company Details
11.24.2 23 Mofang Business Overview
11.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction
11.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.24.5 23 Mofang Recent Development
11.25 Genetic Health
11.25.1 Genetic Health Company Details
11.25.2 Genetic Health Business Overview
11.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction
11.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.25.5 Genetic Health Recent Development
11.26 DNA Services of America
11.26.1 DNA Services of America Company Details
11.26.2 DNA Services of America Business Overview
11.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction
11.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.26.5 DNA Services of America Recent Development
11.27 Shuwen Health Sciences
11.27.1 Shuwen Health Sciences Company Details
11.27.2 Shuwen Health Sciences Business Overview
11.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction
11.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.27.5 Shuwen Health Sciences Recent Development
11.28 Mapmygenome
11.28.1 Mapmygenome Company Details
11.28.2 Mapmygenome Business Overview
11.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction
11.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.28.5 Mapmygenome Recent Development
11.29 Full Genomes
11.29.1 Full Genomes Company Details
11.29.2 Full Genomes Business Overview
11.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction
11.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
11.29.5 Full Genomes Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Celiac Disease
Table 3. Key Players of Parkinson Disease
Table 4. Key Players of Alzheimer Disease
Table 5. Key Players of Other
Table 6. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2016-2021)
Table 10. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2022-2027)
Table 12. Direct-to-consumer Disease Risk and Health Test Market Trends
Table 13. Direct-to-consumer Disease Risk and Health Test Market Drivers
Table 14. Direct-to-consumer Disease Risk and Health Test Market Challenges
Table 15. Direct-to-consumer Disease Risk and Health Test Market Restraints
Table 16. Global Direct-to-consumer Disease Risk and Health Test Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players (2016-2021)
Table 18. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2020)
Table 19. Ranking of Global Top Direct-to-consumer Disease Risk and Health Test Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
Table 23. Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2016-2021)
Table 27. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2016-2021)
Table 31. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2022-2027) & (US$ Million)
Table 63. 23andMe Company Details
Table 64. 23andMe Business Overview
Table 65. 23andMe Direct-to-consumer Disease Risk and Health Test Product
Table 66. 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 67. 23andMe Recent Development
Table 68. MyHeritage Company Details
Table 69. MyHeritage Business Overview
Table 70. MyHeritage Direct-to-consumer Disease Risk and Health Test Product
Table 71. MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 72. MyHeritage Recent Development
Table 73. LabCorp Company Details
Table 74. LabCorp Business Overview
Table 75. LabCorp Direct-to-consumer Disease Risk and Health Test Product
Table 76. LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 77. LabCorp Recent Development
Table 78. Myriad Genetics Company Details
Table 79. Myriad Genetics Business Overview
Table 80. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product
Table 81. Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 82. Myriad Genetics Recent Development
Table 83. Ancestry.com Company Details
Table 84. Ancestry.com Business Overview
Table 85. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product
Table 86. Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 87. Ancestry.com Recent Development
Table 88. Quest Diagnostics Company Details
Table 89. Quest Diagnostics Business Overview
Table 90. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product
Table 91. Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 92. Quest Diagnostics Recent Development
Table 93. Gene By Gene Company Details
Table 94. Gene By Gene Business Overview
Table 95. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product
Table 96. Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 97. Gene By Gene Recent Development
Table 98. DNA Diagnostics Center Company Details
Table 99. DNA Diagnostics Center Business Overview
Table 100. DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 101. DNA Diagnostics Center Recent Development
Table 102. Invitae Company Details
Table 103. Invitae Business Overview
Table 104. Invitae Direct-to-consumer Disease Risk and Health Test Product
Table 105. Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 106. Invitae Recent Development
Table 107. IntelliGenetics Company Details
Table 108. IntelliGenetics Business Overview
Table 109. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product
Table 110. IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 111. IntelliGenetics Recent Development
Table 112. Ambry Genetics Company Details
Table 113. Ambry Genetics Business Overview
Table 114. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product
Table 115. Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 116. Ambry Genetics Recent Development
Table 117. Living DNA Company Details
Table 118. Living DNA Business Overview
Table 119. Living DNA Direct-to-consumer Disease Risk and Health Test Product
Table 120. Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 121. Living DNA Recent Development
Table 122. EasyDNA Company Details
Table 123. EasyDNA Business Overview
Table 124. EasyDNA Direct-to-consumer Disease Risk and Health Test Product
Table 125. EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 126. EasyDNA Recent Development
Table 127. Pathway Genomics Company Details
Table 128. Pathway Genomics Business Overview
Table 129. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product
Table 130. Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 131. Pathway Genomics Recent Development
Table 132. Centrillion Technology Company Details
Table 133. Centrillion Technology Business Overview
Table 134. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product
Table 135. Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 136. Centrillion Technology Recent Development
Table 137. Xcode Company Details
Table 138. Xcode Business Overview
Table 139. Xcode Direct-to-consumer Disease Risk and Health Test Product
Table 140. Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 141. Xcode Recent Development
Table 142. Color Genomics Company Details
Table 143. Color Genomics Business Overview
Table 144. Color Genomics Direct-to-consumer Disease Risk and Health Test Product
Table 145. Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 146. Color Genomics Recent Development
Table 147. Anglia DNA Services Company Details
Table 148. Anglia DNA Services Business Overview
Table 149. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product
Table 150. Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 151. Anglia DNA Services Recent Development
Table 152. African Ancestry Company Details
Table 153. African Ancestry Business Overview
Table 154. African Ancestry Direct-to-consumer Disease Risk and Health Test Product
Table 155. African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 156. African Ancestry Recent Development
Table 157. Canadian DNA Services Company Details
Table 158. Canadian DNA Services Business Overview
Table 159. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product
Table 160. Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 161. Canadian DNA Services Recent Development
Table 162. DNA Family Check Company Details
Table 163. DNA Family Check Business Overview
Table 164. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product
Table 165. DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 166. DNA Family Check Recent Development
Table 167. Alpha Biolaboratories Company Details
Table 168. Alpha Biolaboratories Business Overview
Table 169. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product
Table 170. Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 171. Alpha Biolaboratories Recent Development
Table 172. Test Me DNA Company Details
Table 173. Test Me DNA Business Overview
Table 174. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product
Table 175. Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 176. Test Me DNA Recent Development
Table 177. 23 Mofang Company Details
Table 178. 23 Mofang Business Overview
Table 179. 23 Mofang Direct-to-consumer Disease Risk and Health TestProduct
Table 180. 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 181. 23 Mofang Recent Development
Table 182. Genetic Health Company Details
Table 183. Genetic Health Business Overview
Table 184. Genetic Health Direct-to-consumer Disease Risk and Health Test Product
Table 185. Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 186. Genetic Health Recent Development
Table 187. DNA Services of America Company Details
Table 188. DNA Services of America Business Overview
Table 189. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product
Table 190. DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 191. DNA Services of America Recent Development
Table 192. Shuwen Health Sciences Company Details
Table 193. Shuwen Health Sciences Business Overview
Table 194. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product
Table 195. Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 196. Shuwen Health Sciences Recent Development
Table 197. Mapmygenome Company Details
Table 198. Mapmygenome Business Overview
Table 199. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product
Table 200. Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 201. Mapmygenome Recent Development
Table 202. Full Genomes Company Details
Table 203. Full Genomes Business Overview
Table 204. Full Genomes Direct-to-consumer Disease Risk and Health Test Product
Table 205. Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2016-2021) & (US$ Million)
Table 206. Full Genomes Recent Development
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Direct-to-consumer Disease Risk and Health Test Market Share by Type: 2020 VS 2027
Figure 2. Celiac Disease Features
Figure 3. Parkinson Disease Features
Figure 4. Alzheimer Disease Features
Figure 5. Other Features
Figure 6. Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2020 VS 2027
Figure 7. Online Case Studies
Figure 8. Offline Case Studies
Figure 9. Direct-to-consumer Disease Risk and Health Test Report Years Considered
Figure 10. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions: 2020 VS 2027
Figure 13. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2022-2027)
Figure 14. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players in 2020
Figure 15. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2020
Figure 17. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2016-2021)
Figure 18. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2022-2027)
Figure 19. North America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2016-2027)
Figure 21. North America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2016-2027)
Figure 22. North America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2016-2027)
Figure 23. United States Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Type (2016-2027)
Figure 27. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Application (2016-2027)
Figure 28. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Country (2016-2027)
Figure 29. Germany Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Region (2016-2027)
Figure 39. China Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2016-2027)
Figure 47. Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2016-2027)
Figure 48. Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2016-2027)
Figure 49. Mexico Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Country (2016-2027)
Figure 55. Turkey Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. 23andMe Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 59. MyHeritage Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 60. LabCorp Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 61. Myriad Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 62. Ancestry.com Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 63. Quest Diagnostics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 64. Gene By Gene Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 65. DNA Diagnostics Center Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 66. Invitae Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 67. IntelliGenetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 68. Ambry Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 69. Living DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 70. EasyDNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 71. Pathway Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 72. Centrillion Technology Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 73. Xcode Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 74. Color Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 75. Anglia DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 76. African Ancestry Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 77. Canadian DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 78. DNA Family Check Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 79. Alpha Biolaboratories Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 80. Test Me DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 81. 23 Mofang Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 82. Genetic Health Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 83. DNA Services of America Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 84. Shuwen Health Sciences Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 85. Mapmygenome Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 86. Full Genomes Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2016-2021)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed


★調査レポート[世界の消費者直接提供用病気リスク&健康検査市場規模・現状・予測2021-2027] (コード:QY21JNE3710)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の消費者直接提供用病気リスク&健康検査市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆